Comparative Study of the Efficacy and Safety of Salmeterol Fluticasone with 50/250 μg and 50/500 μg in the Treatment of Aged COPD with Moderate to Sever

LAI Zibiao; CHENG Ying

doi:10.14033/j.cnki.cfmr.2018.11.009

Home>Articles>Comparative Study of the Efficacy and Safety of Salmeterol Fluticasone with 50/250 μg and 50/500 μg in the Treatment of Aged COPD with Moderate to Sever

DOI: 10.14033/j.cnki.cfmr.2018.11.009

Comparative Study of the Efficacy and Safety of Salmeterol Fluticasone with 50/250 μg and 50/500 μg in the Treatment of Aged COPD with Moderate to Sever

LAI Zibiao

CHENG Ying

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 19-20 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2018,16(11)